(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MYMEDS&ME

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

MYMEDS&ME

ST13

US500000079138122

Class

9, 38, 42

Filing

79138122

Registration

4607742

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

03/31/2026

Classification

Registered

Trademark type

Word

Nice classes

9, 38, 42

Filing date

02/15/2013

Registration date

09/23/2014

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/06/2026

Last transaction

03/31/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Aylesbury, GB

Examiner

SOBRAL, CHRISTINA

Law office

L90

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

MyMedsandMe Limited
MyMedsandMe Limited

Representatives

Cynthia A. Moyer Fredrikson & Byron, P.A.

Technical classification

Nice Classes

Class 9Class 38Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

computer software for the collectioneditingorganizingmodifyingbook markingtransmissionstorage and sharing of data and information concerning the qualitysafety and effectiveness of medications and/or pharmaceuticals and reactions and events resulting from the use of medications and/or pharmaceuticals; computer software for capturing and providing information concerning quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and/or pharmaceuticalsenabling follow-up questions and answers regarding said qualityreactions and events and producing reports regarding such qualityreactions and events; computer programs for capturing and providing information concerning the quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticalsfor enabling follow-up questions and answers regarding said qualityreactions and events and for producing reports regarding such qualityreactions and events; computer software applications for capturing information concerning the quality of medication and/or pharmaceuticalsreactions and events resulting from the use of medication and pharmaceuticalsfor enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such qualityreactions and events; computer software for the evaluation and analysis of data and information concerning the qualitysafety and effectiveness of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication and/or pharmaceuticals

Class 38

Telecommunications servicestransmission of data by means of telecommunications networkswireless communication networks and the Internet; telecommunication services for providing multiple user access to a global network; transfer of data by telecommunication; transmission and reception of database information via telecommunications networks; data transmission and reception services via telecommunications means; providing telecommunications connections to databases; electronic exchange of data stored in databases accessible via telecommunication networks; communication servicesproviding electronic transmission of information stored in a database via interactively communicating computer systems; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; information transmission via electronic communications networks; providing multiple user access to proprietary collections of information by means of global computer information networks; telecommunication serviceselectronic exchange of medical records between patients or health care professionals and pharmaceutical companies; telecommunication servicesproviding access to an electronic exchange of medical records between patients or health care professionals and pharmaceutical companies

Class 42

software as a service (SAAS) services featuring software for capturing and providing data concerning the quality of medication and/or pharmaceuticalsreactions and events resulting from the use of medication and/or pharmaceuticalsfor enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such qualityreactions and events; software as a service (SAAS) services featuring software for evaluating and analysing data and information concerning the quality of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication or pharmaceuticals; providing temporary use of on-line non-downloadable software which enables the capture of information concerning the quality of medication and/or pharmaceuticalsreactions and events resulting from the use medication and/or pharmaceuticalsas well as enabling followup questions and answers regarding said qualityreactions and events and enables the production of reports regarding said reactions and events; services for maintenance of computer software; providing temporary use of non-downloadable software allowing web site users to send and receive information concerning the quality of medication and/or pharmaceuticals usedreactions and events resulting from the use of medication and/or pharmaceuticalsanswer (and read answers to) follow-up questions regarding said qualityreactions and events and produce reports regarding said reactions and events; software as a service (SAAS) services featuring software for collectingevaluating and analysing data concerning the quality of medication and/or pharmaceuticals usedreactions and events resulting from the use of medication and/or pharmaceuticals

Publications

History of USPTO decisions and trademark events.

36 publications found

C71T

CANCELLED SECTION 71

03/06/2026

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

09/23/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/21/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/21/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/21/2023

RNWL

INTERNATIONAL REGISTRATION RENEWED

02/03/2023

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

05/12/2021

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

05/12/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/05/2021

ES75

TEAS SECTION 71 & 15 RECEIVED

09/23/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/13/2015

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/26/2015

FIMP

FINAL DISPOSITION PROCESSED

02/26/2015

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/23/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

09/23/2014

GPNX

NOTIFICATION PROCESSED BY IB

07/22/2014

PUBO

PUBLISHED FOR OPPOSITION

07/08/2014

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/02/2014

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/02/2014

NPUB

NOTICE OF PUBLICATION

06/18/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/31/2014

ALIE

ASSIGNED TO LIE

05/31/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/19/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/16/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/15/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/15/2014

RFNT

REFUSAL PROCESSED BY IB

12/10/2013

MAFR

APPLICATION FILING RECEIPT MAILED

11/19/2013

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/15/2013

RFRR

REFUSAL PROCESSED BY MPU

11/14/2013

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/14/2013

CNRT

NON-FINAL ACTION WRITTEN

11/13/2013

DOCK

ASSIGNED TO EXAMINER

11/13/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/13/2013

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

11/12/2013

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/11/2013

Continuous trademark protection

Get notified about every new filing that threatens MYMEDS&ME or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.